• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. OPTIPAC 60 REFOBACIN BONE CEMENT R-3; BONE CEMENT , ANTIBIOTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. OPTIPAC 60 REFOBACIN BONE CEMENT R-3; BONE CEMENT , ANTIBIOTIC Back to Search Results
Catalog Number 4711500396-3
Device Problem Improper Chemical Reaction (2952)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Type  malfunction  
Manufacturer Narrative
(b)(4).The device was not be returned to the manufacturer.Therefore it was not be analyzed.The device manufacturing quality record indicates that the released product met all requirements to perform as intended.With the available information, the exact root cause of the event could not be determined.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.
 
Event Description
It has been reported that it took more than 16 minutes for the bone cement to harden.
 
Event Description
It has been reported that it took more than 16 minutes for the bone cement to harden.
 
Manufacturer Narrative
(b)(4).This follow-up report is being submitted to relay additional information.Reserve sample from the same lot than the product involved in the complaint was evaluated, and showed no abnormal behavior.The reported event was unconfirmed.The device manufacturing quality record indicates that the released product met all requirements to perform as intended.With the available information, the exact root cause of the event could not be determined.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIPAC 60 REFOBACIN BONE CEMENT R-3
Type of Device
BONE CEMENT , ANTIBIOTIC
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
MDR Report Key8353976
MDR Text Key136847612
Report Number3006946279-2019-00110
Device Sequence Number1
Product Code MBB
UDI-Device Identifier04040029922361
UDI-Public(01)04040029922361
Combination Product (y/n)N
PMA/PMN Number
K171540
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign
Type of Report Initial,Followup
Report Date 05/22/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2018
Device Catalogue Number4711500396-3
Device Lot Number636AA05105
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 01/29/2018
Initial Date FDA Received02/20/2019
Supplement Dates Manufacturer Received05/22/2019
Supplement Dates FDA Received05/24/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-